Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 5

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors

Avecilla, Vincent, Doke, Mayur, Appunni, Sandeep, Rubens, Muni, Ramamoorthy, Venkataraghavan, Das, Jayanta Kumar · 2024 · Medical Sciences

Abstract

Vascular diseases, such as hypertension, atherosclerosis, cerebrovascular, and peripheral arterial diseases, present major clinical and public health challenges, largely due to their common underlying process: vascular remodeling. This process involves structural alterations in blood vessels, driven by a variety of molecular mechanisms. The inhibitor of DNA-binding/differentiation-3 (ID3), a crucial member of ID family of transcriptional regulators, has been identified as a key player in vascular biology, significantly impacting the progression of these diseases. This review explores the role of ID3 in vascular remodeling, emphasizing its involvement in processes such as apoptosis, cell proliferation, and extracellular matrix regulation. Furthermore, we examine how oxidative stress, intensified by exposure to estrogenic endocrine disruptors (EEDs) like polychlorinated biphenyls (PCBs) and bisphenol A (BPA), affects ID3 activity and contributes to vascular disease. Understanding the interaction between ID3 signaling and EED exposure provides critical insights into the molecular mechanisms underlying vascular remodeling and its role in the development and progression of vascular diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/medsci13010002

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 109

  1. Mikolajczyk, 2024, Vascular remodelling in cardiovascular diseases: Hypertension, oxidation, and inflammation, Clin. Sci., 138, 817, 10.1042/CS20220797 · DOI
  2. Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., and Opie, L. (2014). Lancet Seminar: Cardiovascular Remodelling in Coronary Artery Disease and Heart Failure. Lancet, 383. · DOI · Paper page
  3. Van Varik, B.J., Rennenberg, R.J.M.W., Reutelingsperger, C.P., Kroon, A.A., De Leeuw, P.W., and Schurgers, L.J. (2012). Mechanisms of arterial remodeling: Lessons from genetic diseases. Front. Genet., 3. · DOI · Paper page
  4. Melo, 2007, Vascular Remodeling in Health and Disease, Cardiovasc. Med., 50, 1541, 10.1007/978-1-84628-715-2_74 · DOI
  5. Weissman, 2003, Vascular remodeling: Do we really need yet another study?, J. Am. Coll. Cardiol., 42, 811, 10.1016/S0735-1097(03)00841-6 · doi:10.1016/s0735-1097(03)00841-6
  6. Carpenter, 2006, Polychlorinated biphenyls (PCBs): Routes of exposure and effects on human health, Rev. Environ. Health, 21, 1, 10.1515/REVEH.2006.21.1.1 · DOI · Paper page
  7. Rubin, 2011, Bisphenol A: An endocrine disruptor with widespread exposure and multiple effects, J. Steroid Biochem. Mol. Biol., 127, 27, 10.1016/j.jsbmb.2011.05.002 · DOI · Paper page
  8. Newbold, 2004, Lessons learned from perinatal exposure to diethylstilbestrol, Toxicol. Appl. Pharmacol., 199, 142, 10.1016/j.taap.2003.11.033 · DOI · Paper page
  9. Kirkley, 2014, Environmental Endocrine Disruption of Energy Metabolism and Cardiovascular Risk, Curr. Diab. Rep., 14, 494, 10.1007/s11892-014-0494-0 · DOI
  10. Werner, 2015, The association between maternal urinary phthalate concentrations and blood pressure in pregnancy: The HOME Study, Environ. Health, 14, 75, 10.1186/s12940-015-0062-3 · DOI
  11. Park, 2016, Body burden of persistent organic pollutants on hypertension: A meta-analysis, Environ. Sci. Pollut. Res. Int., 23, 14284, 10.1007/s11356-016-6568-6 · DOI
  12. Das, J.K., and Felty, Q. (2014). PCB153-induced overexpression of ID3 contributes to the development of microvascular lesions. PLoS ONE, 9. · DOI
  13. Avecilla, V., Doke, M., and Felty, Q. (2017). Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease. BioMed Res. Int., 2017. · DOI
  14. Fonseca, 2022, Endocrine-Disrupting Effects of Bisphenol A on the Cardiovascular System: A Review, J. Xenobiotics, 12, 181, 10.3390/jox12030015 · DOI
  15. Doke, 2018, Abstract 5052: ID3 mediated vascular reprogramming of PCB exposed endothelial cells and its potential contribution to lung tumorigenicity, Cancer Res., 78, 5052, 10.1158/1538-7445.AM2018-5052 · doi:10.1158/1538-7445.am2018-5052
  16. Doke, M., Felty, Q., and Das, J. (2017). The role of environmental chemical PCB153 in aggressive growth of plexiform lesions associated with lung cancer. Eur. J. Surg. Oncol., 43. · doi:10.1016/j.ejso.2017.10.119
  17. Wahlang, 2017, Editor’s Highlight: PCB126 Exposure Increases Risk for Peripheral Vascular Diseases in a Liver Injury Mouse Model, Toxicol. Sci., 160, 256, 10.1093/toxsci/kfx180 · DOI
  18. Felty, 2011, Proteomic 2D DIGE profiling of human vascular endothelial cells exposed to environmentally relevant concentration of endocrine disruptor PCB153 and physiological concentration of 17β-estradiol, Cell Biol. Toxicol., 27, 49, 10.1007/s10565-010-9170-6 · DOI
  19. Das, J.K., and Felty, Q.H. (2013). Abstract 3899: PCB153-induced angiogenesis depends on redoxsensitive Pyk2 signaling. Cancer Res., 73. · doi:10.1158/1538-7445.am2013-3899
  20. Doke, M., Avecilla, V., and Felty, Q. (2018). Inhibitor of Differentiation-3 and Estrogenic Endocrine Disruptors: Implications for Susceptibility to Obesity and Metabolic Disorders. BioMed Res. Int., 2018. · DOI
  21. Vastolo, 2018, High-fat diet unveils an enhancer element at the Ped/Pea-15 gene responsible for epigenetic memory in skeletal muscle, Metabolism, 87, 70, 10.1016/j.metabol.2018.06.001 · DOI
  22. Ciccarelli, 2016, Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle, Diabetologia, 59, 176, 10.1007/s00125-015-3774-6 · DOI
  23. Felty, 2008, Estrogen-induced redox sensitive Id3 signaling controls the growth of vascular cells, Atherosclerosis, 198, 12, 10.1016/j.atherosclerosis.2007.12.048 · DOI
  24. Davignon, 2004, Role of endothelial dysfunction in atherosclerosis, Circulation, 109, III27, 10.1161/01.CIR.0000131515.03336.f8 · DOI · Paper page
  25. Yilmaz, 2019, Endocrine disrupting chemicals: Exposure, effects on human health, mechanism of action, models for testing and strategies for prevention, Rev. Endocr. Metab. Disord., 21, 127, 10.1007/s11154-019-09521-z · DOI · Paper page
  26. Poulsen, 2001, Genetic versus environmental aetiology of the metabolic syndrome among male and female twins, Diabetologia, 44, 537, 10.1007/s001250051659 · DOI · Paper page
  27. Lim, 2005, Molecular mechanisms regulating expression and function of transcription regulator “inhibitor of differentiation 3”, Acta Pharmacol. Sin., 26, 1409, 10.1111/j.1745-7254.2005.00207.x · DOI
  28. Patti, 2002, Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention, Am. J. Cardiol., 89, 372, 10.1016/S0002-9149(01)02254-8 · doi:10.1016/s0002-9149(01)02254-8
  29. Sakurai, 2004, Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells, J. Immunol., 173, 5801, 10.4049/jimmunol.173.9.5801 · DOI
  30. Eelen, 2015, Endothelial cell metabolism in normal and diseased vasculature, Circ. Res., 116, 1231, 10.1161/CIRCRESAHA.116.302855 · DOI · Paper page
  31. Epstein, 1994, The emerging concept of vascular remodeling, N. Engl. J. Med., 330, 1431, 10.1056/NEJM199405193302008 · DOI · Paper page
  32. Chakrabarti, 2009, 12/15-Lipoxygenase Products Induce Inflammation and Impair Insulin Signaling in 3T3-L1 Adipocytes, Obesity, 17, 1657, 10.1038/oby.2009.192 · DOI
  33. Taylor, 2005, The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth, Arterioscler. Thromb. Vasc. Biol., 25, 2069, 10.1161/01.ATV.0000178992.40088.f2 · doi:10.1161/01.atv.0000178992.40088.f2
  34. Das, 2015, ID3 Contributes to the Acquisition of Molecular Stem Cell-Like Signature in Microvascular Endothelial Cells: Its implication for understanding microvascular diseases, Microvasc. Res., 98, 126, 10.1016/j.mvr.2015.01.006 · doi:10.1016/j.mvr.2015.01.006
  35. Funder, J.W. (2017). Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology. Int. J. Mol. Sci., 18. · DOI
  36. Wassmann, 2010, Interaction of inhibitor of DNA binding 3 (Id3) with Gut-enriched Krüppel-like factor (GKLF) and p53 regulates proliferation of vascular smooth muscle cells, Mol. Cell Biochem., 333, 33, 10.1007/s11010-009-0201-7 · doi:10.1007/s11010-009-0201-7
  37. Wang, 2024, Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD, Blood, 143, 166, 10.1182/blood.2023021126 · DOI
  38. Bakr, A., Hey, J., Sigismondo, G., Liu, C.S., Sadik, A., Goyal, A., Cross, A., Iyer, R.L., Müller, P., and Trauernicht, M. (2021). ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition. Nucleic Acids Res., 49. · DOI
  39. Loveys, 1996, E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein, Nucleic Acids Res., 24, 2813, 10.1093/nar/24.14.2813 · DOI
  40. Lyden, 1999, Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts, Nature, 401, 670, 10.1038/44334 · DOI · Paper page
  41. Fishman, 1998, Mechanisms of proliferative and obliterative vascular diseases. Insights from the pulmonary and systemic circulations. NHLBI Workshop summary, Am. J. Respir. Crit. Care Med., 158, 670, 10.1164/ajrccm.158.2.9803084 · DOI
  42. Fraidenraich, 2004, Rescue of cardiac defects in Id knockout embryos by injection of embryonic stem cells, Science, 306, 247, 10.1126/science.1102612 · DOI · Paper page
  43. Humphrey, 2021, Vascular Mechanobiology: Homeostasis, Adaptation, and Disease, Annu. Rev. Biomed. Eng., 23, 1, 10.1146/annurev-bioeng-092419-060810 · DOI · Paper page
  44. Aird, 2012, Endothelial cell heterogeneity, Cold Spring Harb. Perspect. Med., 2, S221, 10.1101/cshperspect.a006429 · DOI · Paper page
  45. Nakane, 2000, Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction, Hypertension, 35, 595, 10.1161/01.HYP.35.2.595 · DOI
  46. Sack, 2002, Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease, Pharmacol. Ther., 94, 123, 10.1016/S0163-7258(02)00176-6 · DOI
  47. Abrams, 1991, Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes, J. Exp. Med., 174, 1209, 10.1084/jem.174.5.1209 · DOI · Paper page
  48. Briones, 2010, Role of extracellular matrix in vascular remodeling of hypertension, Curr. Opin. Nephrol. Hypertens., 19, 187, 10.1097/MNH.0b013e328335eec9 · DOI
  49. Min, 2005, Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells, Circ. Res., 97, 434, 10.1161/01.RES.0000180753.63183.95 · DOI · Paper page
  50. Xu, Q., Zhuo, K., Zhang, X., Zhen, Y., Liu, L., Zhang, L., Gu, Y., Jia, H., Chen, Q., and Liu, M. (2024). The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling. Eur. J. Pharmacol., 962. · DOI
  51. Doke, M., and Felty, Q.H. (2016). Abstract 3274: VEGF─receptor antagonist, Sugen 5416, sensitizes pulmonary endothelial stem-like cells to estrogens: A microvascular model for the progression of lung cancer. Cancer Res., 76. · doi:10.1158/1538-7445.am2016-3274
  52. Daugherty, 2004, Angiotensin II-Mediated Development of Vascular Diseases, Trends Cardiovasc. Med., 14, 117, 10.1016/j.tcm.2004.01.002 · DOI
  53. Savoia, 2006, Inflammation in hypertension, Curr. Opin. Nephrol. Hypertens., 15, 152
  54. Carey, 2003, The intrarenal renin-angiotensin system and diabetic nephropathy, Trends Endocrinol. Metab., 14, 274, 10.1016/S1043-2760(03)00111-5 · DOI · Paper page
  55. Forrest, 2004, Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation, J. Biol. Chem., 279, 32897, 10.1074/jbc.M404882200 · DOI
  56. Deliri, 2011, Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury, Arterioscler. Thromb. Vasc. Biol., 31, 110, 10.1161/ATVBAHA.110.212068 · DOI
  57. Matsumura, 2001, Vascular injury induces posttranscriptional regulation of the Id3 gene: Cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 21, 752, 10.1161/01.ATV.21.5.752 · DOI
  58. Mueller, 2002, Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth, Circulation, 105, 2423, 10.1161/01.CIR.0000016047.19488.91 · DOI
  59. Cutchins, 2012, Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion, Arterioscler. Thromb. Vasc. Biol., 32, 317, 10.1161/ATVBAHA.111.234856 · DOI
  60. Harmon, 2016, Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance, Arterioscler. Thromb. Vasc. Biol., 36, 682, 10.1161/ATVBAHA.116.307166 · DOI
  61. Srikakulapu, P., Upadhye, A., Rosenfeld, S.M., Marshall, M.A., McSkimming, C., Hickman, A.W., Mauldin, I.S., Ailawadi, G., Lopes, M.B.S., and Taylor, A.M. (2017). Perivascular adipose tissue harbors atheroprotective IgM-producing B cells. Front. Physiol., 8. · DOI
  62. Yang, J., Li, X., Li, Y., Southwood, M., Ye, L., Long, L., Al-Lamki, R.S., and Morrell, N.W. (2013). Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol., 305. · DOI
  63. Mair, 2015, Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells, Am. J. Respir. Crit. Care Med., 191, 693, 10.1164/rccm.201410-1802OC · DOI
  64. Doran, 2010, Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans, Circ. Res., 106, 1303, 10.1161/CIRCRESAHA.109.210294 · DOI
  65. Manichaikul, A., Rich, S.S., Perry, H., Yeboah, J., Law, M., Davis, M., Parker, M., Ragosta, M., Connelly, J.J., and McNamara, C.A. (2014). A Functionally Significant Polymorphism in ID3 Is Associated with Human Coronary Pathology. PLoS ONE, 9. · DOI
  66. Shi, 2017, Systematic analysis of coronary artery disease datasets revealed the potential biomarker and treatment target, Oncotarget, 8, 54583, 10.18632/oncotarget.17426 · doi:10.18632/oncotarget.17426
  67. Romero, 2013, The angiogenic gene profile of circulating endothelial progenitor cells from ischemic stroke patients, Vasc. Cell, 5, 3, 10.1186/2045-824X-5-3 · DOI
  68. Chantler, 2017, Stroke-associated pattern of gene expression previously identified by machine-learning is diagnostically robust in an independent patient population, Genom. Data, 14, 47, 10.1016/j.gdata.2017.08.006 · DOI
  69. Christensen, K.L.Y., and White, P. (2011). A Methodological Approach to Assessing the Health Impact of Environmental Chemical Mixtures: PCBs and Hypertension in the National Health and Nutrition Examination Survey. Int. J. Environ. Res. Public Health, 8. · DOI
  70. Lind, 2014, Circulating levels of p,p′-DDE are related to prevalent hypertension in the elderly, Environ. Res., 129, 27, 10.1016/j.envres.2013.12.003 · DOI
  71. Gea, 2015, Association between dietary intake of polychlorinated biphenyls and the incidence of hypertension in a Spanish cohort: The Seguimiento Universidad de Navarra project, Hypertension, 65, 714, 10.1161/HYPERTENSIONAHA.114.04435 · DOI
  72. Ehrlich, 2024, Data-driven derivation of an adverse outcome pathway linking vascular endothelial growth factor receptor (VEGFR), endocrine disruption, and atherosclerosis, ALTEX Altern. Anim. Exp., 41, 617
  73. Avecilla, V., Doke, M., Das, M., Alcazar, O., Appunni, S., Rech Tondin, A., Watts, B., Ramamoorthy, V., Rubens, M., and Das, J.K. (2024). Integrative Bioinformatics–Gene Network Approach Reveals Linkage between Estrogenic Endocrine Disruptors and Vascular Remodeling in Peripheral Arterial Disease. Int. J. Mol. Sci., 25. · DOI · Paper page
  74. Halder, 2023, β1 integrin is essential for blood–brain barrier integrity under stable and vascular remodelling conditions; effects differ with age, Fluids Barriers CNS, 20, 52, 10.1186/s12987-023-00453-0 · DOI
  75. Evans, B.R., Yerly, A., van der Vorst, E.P.C., Baumgartner, I., Bernhard, S.M., Schindewolf, M., and Döring, Y. (2022). Inflammatory Mediators in Atherosclerotic Vascular Remodeling. Front. Cardiovasc. Med., 9. · DOI
  76. Liu, 2015, Exposure to coplanar PCBs induces endothelial cell inflammation through epigenetic regulation of NF-κB subunit p65, Toxicol. Appl. Pharmacol., 289, 457, 10.1016/j.taap.2015.10.015 · DOI
  77. Felty, 2010, Gene expression profile of endothelial cells exposed to estrogenic environmental compounds: Implications to pulmonary vascular lesions, Life Sci., 86, 919, 10.1016/j.lfs.2010.04.007 · DOI
  78. Shankar, 2012, Peripheral Arterial Disease: Results from the NHANES, Environ. Health Perspect., 120, 1297, 10.1289/ehp.1104114 · DOI · Paper page
  79. Lin, 2015, Association between levels of serum bisphenol A, a potentially harmful chemical in plastic containers, and carotid artery intima-media thickness in adolescents and young adults, Atherosclerosis, 241, 657, 10.1016/j.atherosclerosis.2015.06.038 · DOI
  80. Fang, 2015, Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits, J. Appl. Toxicol., 35, 1058, 10.1002/jat.3103 · DOI
  81. Hu, 2016, Bisphenol A, an environmental estrogen-like toxic chemical, induces cardiac fibrosis by activating the ERK1/2 pathway, Toxicol. Lett., 250–251, 1, 10.1016/j.toxlet.2016.03.008 · DOI
  82. Belcher, 2015, Bisphenol A alters autonomic tone and extracellular matrix structure and induces sex-specific effects on cardiovascular function in male and female CD-1 mice, Endocrinology, 156, 882, 10.1210/en.2014-1847 · DOI
  83. Saura, 2014, Oral administration of bisphenol A induces high blood pressure through angiotensin II/CaMKII-dependent uncoupling of eNOS, FASEB J., 28, 4719, 10.1096/fj.14-252460 · DOI
  84. Lind, 2011, Circulating levels of bisphenol A and phthalates are related to carotid atherosclerosis in the elderly, Atherosclerosis, 218, 207, 10.1016/j.atherosclerosis.2011.05.001 · DOI · Paper page
  85. Murphy, 2011, Estrogen signaling and cardiovascular disease, Circ. Res., 109, 687, 10.1161/CIRCRESAHA.110.236687 · DOI · Paper page
  86. Cleutjens, 2001, 17beta-estradiol attenuates the development of pressure-overload hypertrophy, Circulation, 104, 1419, 10.1161/hc3601.095577 · DOI · Paper page
  87. Nuedling, 1999, 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo, Cardiovasc. Res., 43, 666, 10.1016/S0008-6363(99)00093-0 · DOI · Paper page
  88. Mendelsohn, 2002, Protective effects of estrogen on the cardiovascular system, Am. J. Cardiol., 89, 12, 10.1016/S0002-9149(02)02405-0 · DOI · Paper page
  89. Umar, 2012, Estrogen paradox in pulmonary hypertension: Current controversies and future perspectives, Am. J. Respir. Crit. Care Med., 186, 125, 10.1164/rccm.201201-0058PP · DOI
  90. Lahm, 2014, Progress in solving the sex hormone paradox in pulmonary hypertension, Am. J. Physiol. Lung Cell Mol. Physiol., 307, L7, 10.1152/ajplung.00337.2013 · DOI · Paper page
  91. Das, 2015, Microvascular lesions by estrogen-induced ID3: Its implications in cerebral and cardiorenal vascular disease, J. Mol. Neurosci., 55, 618, 10.1007/s12031-014-0401-9 · DOI
  92. Felty, 2005, Estrogen, mitochondria, and growth of cancer and non-cancer cells, J. Carcinog., 4, 1, 10.1186/1477-3163-4-1 · DOI
  93. Hopkins, 2013, Molecular biology of atherosclerosis, Physiol. Rev., 93, 1317, 10.1152/physrev.00004.2012 · DOI · Paper page
  94. So, B., Park, J., Jang, J., Lim, W., Imdad, S., and Kang, C. (2022). Effect of Aerobic Exercise on Oxidative Stress and Inflammatory Response During Particulate Matter Exposure in Mouse Lungs. Front. Physiol., 12. · DOI
  95. Wu, L., Xiong, X., Wu, X., Ye, Y., Jian, Z., Zhi, Z., and Gu, L. (2020). Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury. Front. Mol. Neurosci., 13. · DOI · Paper page
  96. Avecilla, V. (2019). Effect of Transcriptional Regulator ID3 on Pulmonary Arterial Hypertension and Hereditary Hemorrhagic Telangiectasia. Int. J. Vasc. Med., 2019. · DOI
  97. Yang, 2014, Id proteins in the vasculature: From molecular biology to cardiopulmonary medicine, Cardiovasc. Res., 104, 388, 10.1093/cvr/cvu215 · DOI
  98. Crosswhite, 2014, Molecular mechanisms of pulmonary arterial remodeling, Mol. Med., 20, 191, 10.2119/molmed.2013.00165 · DOI
  99. Helsley, R.N., and Zhou, C. (2017). Epigenetic impact of endocrine disrupting chemicals on lipid homeostasis and atherosclerosis: A pregnane X receptor-centric view. Environ. Epigenet., 3. · DOI
  100. Lința, A.V., Lolescu, B.M., Ilie, C.A., Vlad, M., Blidișel, A., Sturza, A., Borza, C., Muntean, D.M., and Crețu, O.M. (2024). Liver and Pancreatic Toxicity of Endocrine-Disruptive Chemicals: Focus on Mitochondrial Dysfunction and Oxidative Stress. Int. J. Mol. Sci., 25. · DOI
  101. 2024, Oxidative Stress and Its Biomarkers in Cardiovascular Diseases, Artery Res., 30, 18, 10.1007/s44200-024-00062-8 · DOI
  102. Mussbacher, M., Derler, M., Basílio, J., and Schmid, J.A. (2023). NF-κB in monocytes and macrophages—An inflammatory master regulator in multitalented immune cells. Front. Immunol., 14. · DOI · Paper page
  103. Hansen, J.F., Bendtzen, K., Boas, M., Frederiksen, H., Nielsen, C.H., Rasmussen, K., and Feldt-Rasmussen, U. (2015). Influence of Phthalates on Cytokine Production in Monocytes and Macrophages: A Systematic Review of Experimental Trials. PLoS ONE, 10. · DOI
  104. McDonald, 1997, Activation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils, Blood, 89, 3421, 10.1182/blood.V89.9.3421 · DOI · Paper page
  105. Guan, 2024, Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis, Curr. Atheroscler. Rep., 26, 411, 10.1007/s11883-024-01220-8 · DOI
  106. Durham, 2018, Role of smooth muscle cells in vascular calcification: Implications in atherosclerosis and arterial stiffness, Cardiovasc. Res., 114, 590, 10.1093/cvr/cvy010 · DOI · Paper page
  107. Cao, 2022, How vascular smooth muscle cell phenotype switching contributes to vascular disease, Cell Commun. Signal., 20, 180, 10.1186/s12964-022-00993-2 · DOI · Paper page
  108. Migliaccio, S., Bimonte, V.M., Besharat, Z.M., Sabato, C., Lenzi, A., Crescioli, C., and Ferretti, E. (2022). Environmental Contaminants Acting as Endocrine Disruptors Modulate Atherogenic Processes: New Risk Factors for Cardiovascular Diseases in Women?. Biomolecules, 12. · doi:10.20944/preprints202111.0300.v1
  109. Muntean, D.M., Linţa, A.V., Ionică, L.N., Dănilă, M.D., Lighezan, D.F., and Sturza, A. (2024). Vascular Toxicity of Endocrine Disruptors: A Thinly Veiled Threat. Environmental Factors in the Pathogenesis of Cardiovascular Disease, Springer Nature. · DOI

Metadata

Authors
Avecilla, V., Doke, M., Appunni, S., Rubens, M., Ramamoorthy, V., & Das, J. K.
Venue
Medical Sciences
Publisher
MDPI AG
Published
2024-12-26
Volume
13
Issue
1
Pages
2
ISSN
2076-3271
Cited by
5
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors. https://app.cochat.ai/papers/10.3390/medsci13010002
The paper
Avecilla, V., Doke, M., Appunni, S., Rubens, M., Ramamoorthy, V., & Das, J. K. (2024). Pathophysiological Features of Remodeling in Vascular Diseases: Impact of Inhibitor of DNA-Binding/Differentiation-3 and Estrogenic Endocrine Disruptors. Medical Sciences. https://doi.org/10.3390/medsci13010002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.